We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Removing More Blood Improves Hemorrhagic Stroke Recovery

By HospiMedica International staff writers
Posted on 26 Feb 2019
The greater the volume of blood removed from the brain following cerebral hemorrhage, the greater the odds of better functional recovery, claims a new study.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA), the University of Chicago (IL, USA), and 76 other hospitals in the USA, Canada, Europe, Australia, and Asia conducted a phase 3 clinical trial in order to assess if minimally invasive catheter evacuation of blood clots, followed by thrombolysis (with the aim of decreasing the clot size to 15 mL or less), could improve functional outcome in 242 patients (average age 62 years, 63% male) who underwent an intracerebral hemorrhage (ICH) event.

The procedure, called minimally invasive surgery plus alteplase for intracerebral hemorrhage evacuation (MISTIE) starts with computerized tomography (CT)-based navigation to develop a surgical approach plan, after which a rigid cannula is placed in the middle of the intracerebral blood clot. More...
Surgeons then insert a soft drainage catheter, which facilitates up to nine injections of alteplase and passive clot removal. Evacuation is stopped when a hematoma size of 15 mL or less is achieved, as confirmed by daily CT scans.

Study results revealed that at one year, the proportion of patients with a modified Rankin Scale (mRS) score of 3 or less was not significantly higher in patients treated with the procedure (45%), compared to those who received standard medical care (41%). However, exploratory secondary analysis found that among the 58% of patients who had their hematoma reduced to a volume of 15 mL or less, there was a 10.5% difference in the likelihood of achieving a good functional outcome. The study was presented at the annual International Stroke Conference, held during January 2019 in Honolulu (Hawaii, USA).

“When assessing the results of surgery for brain hemorrhage, it is critical to consider how much blood was successfully evacuated. Unless a large majority of clot is removed and only a very small residual of blood is left, the full benefits of surgery will not be realized,” said senior author Professor Issam Awad, MD, MSc, of the University of Chicago. “This had never been considered as a factor in the success or failure of such surgeries, and cannot be taken for granted.”

Acute stroke due to supratentorial ICH is associated with high morbidity and mortality. Trials have not shown a benefit of hematoma evacuation with open craniotomy, and current guidelines have called for more evidence before making any recommendations about routine use of surgical interventions in this setting.

Related Links:
Johns Hopkins University
University of Chicago


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.